Literature DB >> 27466323

Dynamic cohesin-mediated chromatin architecture controls epithelial-mesenchymal plasticity in cancer.

Jiyeon Yun1, Sang-Hyun Song2, Hwang-Phill Kim2, Sae-Won Han3, Eugene C Yi4, Tae-You Kim5.   

Abstract

Epithelial to mesenchymal transition (EMT) and mesenchymal to epithelial transition (MET) are important interconnected events in tumorigenesis controlled by complex genetic networks. However, the cues that activate EMT-initiating factors and the mechanisms that reversibly connect EMT/MET are not well understood. Here, we show that cohesin-mediated chromatin organization coordinates EMT/MET by regulating mesenchymal genes. We report that RAD21, a subunit of the cohesin complex, is expressed in epithelial breast cancer cells, whereas its expression is decreased in mesenchymal cancer. Depletion of RAD21 in epithelial cancer cells causes transcriptional activation of TGFB1 and ITGA5, inducing EMT. Reduced binding of RAD21 changes intrachromosomal chromatin interactions within the TGFB1 and ITGA5 loci, creating an active transcriptional environment. Similarly, stem cell-like cancer cells also show an open chromatin structure at both genes, which correlates with high expression levels and mesenchymal fate characteristics. Conversely, overexpression of RAD21 in mesenchymal cancer cells induces MET-specific expression patterns. These findings indicate that dynamic cohesin-mediated chromatin structures are responsible for the initiation and regulation of essential EMT-related cell fate changes in cancer.
© 2016 The Authors.

Entities:  

Keywords:  EMT; cancer stem cell; cohesin; higher‐order chromatin structure

Mesh:

Substances:

Year:  2016        PMID: 27466323      PMCID: PMC5007572          DOI: 10.15252/embr.201541852

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  75 in total

1.  Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state.

Authors:  Christine L Chaffer; Ines Brueckmann; Christina Scheel; Alicia J Kaestli; Paul A Wiggins; Leonardo O Rodrigues; Mary Brooks; Ferenc Reinhardt; Ying Su; Kornelia Polyak; Lisa M Arendt; Charlotte Kuperwasser; Brian Bierie; Robert A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-15       Impact factor: 11.205

Review 2.  A perspective on cancer cell metastasis.

Authors:  Christine L Chaffer; Robert A Weinberg
Journal:  Science       Date:  2011-03-25       Impact factor: 47.728

3.  Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1.

Authors:  Oscar H Ocaña; Rebeca Córcoles; Angels Fabra; Gema Moreno-Bueno; Hervé Acloque; Sonia Vega; Alejandro Barrallo-Gimeno; Amparo Cano; M Angela Nieto
Journal:  Cancer Cell       Date:  2012-11-29       Impact factor: 31.743

Review 4.  Tumor progression and metastasis.

Authors:  J Yokota
Journal:  Carcinogenesis       Date:  2000-03       Impact factor: 4.944

5.  EMT and MET in metastasis: where are the cancer stem cells?

Authors:  Thomas Brabletz
Journal:  Cancer Cell       Date:  2012-12-11       Impact factor: 31.743

Review 6.  Enhancer function: new insights into the regulation of tissue-specific gene expression.

Authors:  Chin-Tong Ong; Victor G Corces
Journal:  Nat Rev Genet       Date:  2011-03-01       Impact factor: 53.242

Review 7.  Synthetic lethality and cancer: cohesin and PARP at the replication fork.

Authors:  Nigel J O'Neil; Derek M van Pel; Philip Hieter
Journal:  Trends Genet       Date:  2013-01-18       Impact factor: 11.639

8.  Testican-1-mediated epithelial-mesenchymal transition signaling confers acquired resistance to lapatinib in HER2-positive gastric cancer.

Authors:  H-P Kim; S-W Han; S-H Song; E-G Jeong; M-Y Lee; D Hwang; S-A Im; Y-J Bang; T-Y Kim
Journal:  Oncogene       Date:  2013-07-22       Impact factor: 9.867

9.  RAD21 and KIAA0196 at 8q24 are amplified and overexpressed in prostate cancer.

Authors:  Kati P Porkka; Teuvo L J Tammela; Robert L Vessella; Tapio Visakorpi
Journal:  Genes Chromosomes Cancer       Date:  2004-01       Impact factor: 5.006

10.  Reduced cohesin destabilizes high-level gene amplification by disrupting pre-replication complex bindings in human cancers with chromosomal instability.

Authors:  Jiyeon Yun; Sang-Hyun Song; Jee-Youn Kang; Jinah Park; Hwang-Phill Kim; Sae-Won Han; Tae-You Kim
Journal:  Nucleic Acids Res       Date:  2015-09-29       Impact factor: 16.971

View more
  11 in total

1.  Dynamic cohesin-mediated chromatin architecture controls epithelial-mesenchymal plasticity in cancer.

Authors:  Jiyeon Yun; Sang-Hyun Song; Hwang-Phill Kim; Sae-Won Han; Eugene C Yi; Tae-You Kim
Journal:  EMBO Rep       Date:  2016-07-27       Impact factor: 8.807

2.  miR-27b Suppresses Tongue Squamous Cell Carcinoma Epithelial-Mesenchymal Transition by Targeting ITGA5.

Authors:  Tao Li; Qian Wu; Duanqin Liu; Xuxia Wang
Journal:  Onco Targets Ther       Date:  2020-11-17       Impact factor: 4.147

Review 3.  Emerging themes in cohesin cancer biology.

Authors:  Todd Waldman
Journal:  Nat Rev Cancer       Date:  2020-06-08       Impact factor: 60.716

Review 4.  Integrins in the Spotlight of Cancer.

Authors:  Daniela Bianconi; Matthias Unseld; Gerald W Prager
Journal:  Int J Mol Sci       Date:  2016-12-06       Impact factor: 5.923

Review 5.  CTCF, Cohesin, and Chromatin in Human Cancer.

Authors:  Sang-Hyun Song; Tae-You Kim
Journal:  Genomics Inform       Date:  2017-12-29

6.  Exploration of prognosis-related microRNA and transcription factor co-regulatory networks across cancer types.

Authors:  Ruijiang Li; Shuai Jiang; Wanying Li; Hao Hong; Chenghui Zhao; Xin Huang; Zhuo Zhang; Hao Li; Hebing Chen; Xiaochen Bo
Journal:  RNA Biol       Date:  2019-05-03       Impact factor: 4.652

7.  ARID1A deficiency weakens BRG1-RAD21 interaction that jeopardizes chromatin compactness and drives liver cancer cell metastasis.

Authors:  Xue-Ying Shang; Yi Shi; Dan-Dan He; Lan Wang; Qing Luo; Chuan-Huai Deng; Yu-Lan Qu; Na Wang; Ze-Guang Han
Journal:  Cell Death Dis       Date:  2021-10-23       Impact factor: 8.469

8.  Prognostic Values and Underlying Regulatory Network of Cohesin Subunits in Esophageal Carcinoma.

Authors:  Wenqiang Gan; Weiqi Wang; Tiegang Li; Rixin Zhang; Yufang Hou; Silin Lv; Zifan Zeng; Zheng Yan; Min Yang
Journal:  J Cancer       Date:  2022-03-06       Impact factor: 4.207

Review 9.  Cohesin Mutations in Cancer: Emerging Therapeutic Targets.

Authors:  Jisha Antony; Chue Vin Chin; Julia A Horsfield
Journal:  Int J Mol Sci       Date:  2021-06-24       Impact factor: 5.923

10.  SNAI1-Driven Sequential EMT Changes Attributed by Selective Chromatin Enrichment of RAD21 and GRHL2.

Authors:  Vignesh Sundararajan; Ming Tan; Tuan Zea Tan; Qing You Pang; Jieru Ye; Vin Yee Chung; Ruby Yun-Ju Huang
Journal:  Cancers (Basel)       Date:  2020-05-02       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.